NFKBIE and B-cell chronic lymphocytic leukemia: Mutations in the NFKBIE gene, which encodes the IκBε inhibitor, have been reported at frequencies ranging from 4% to 11% of untreated CLL patients and have been associated with shorter treatment-free survival and overall survival in patients treated with chemoimmunotherapy [12–16].